Voluntarily recall of two lots of intravenous (IV) fluids


FDA report “Baxter International Inc. announced it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital/user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to patient administration and there have been no adverse events associated with this issue reported to Baxter.”

Full Alert

Thank you to our partners for supporting IVTEAM


Comments are closed.